Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Agoniste canal potassium")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 426

  • Page / 18
Export

Selection :

  • and

The potassium channel opener levcromakalim causes expansive remodelling of experimental vein graftsWALES, Lucy; GOSLING, Martin; TAYLOR, Graham W et al.Journal of vascular surgery. 2006, Vol 44, Num 1, pp 159-165, issn 0741-5214, 7 p.Article

Pharmacology of UR-8225, a new potassium channel openerTAMARGO, J; PEREZ, O; DELPON, E et al.Cardiovascular drug reviews (Print). 1996, Vol 14, Num 3, pp 256-271, issn 0897-5957Article

Use of intermediate/small conductance calcium-activated potassium-channel activator for endothelial protectionQIN YANG; HUANG, Jun-Hao; MAN, Yu-Bun et al.Journal of thoracic and cardiovascular surgery (Print). 2011, Vol 141, Num 2, pp 501-510, issn 0022-5223, 10 p.Article

Potassium channels as anti-epileptic drug targetsWICKENDEN, Alan D.Neuropharmacology. 2002, Vol 43, Num 7, pp 1055-1060, issn 0028-3908, 6 p.Article

Nicorandil : ulcérations intestinales graves, entre autres = Nicorandil : intestinal severe ulcerationsLa Revue Prescrire. 2007, Vol 27, Num 290, pp 910-911, issn 0247-7750, 2 p.Article

Diazoxide in the treatment of schizophrenia: novel application of potassium channel openers in the treatment of schizophreniaAKHONDZADEH, S; MOJTAHEDZADEH, V; MIRSEPASSI, G.-R et al.Journal of clinical pharmacy and therapeutics (Print). 2002, Vol 27, Num 6, pp 453-459, issn 0269-4727, 7 p.Article

Nicorandil and calcium antagonists: remember oro-anal ulceration and reflux cough tooMEDFORD, Andrew R. L.Clinical medicine. 2013, Vol 13, Num 3, issn 1470-2118, p. 323Article

Nicorandil: ulcérations cutanéomuqueuses (suite)La Revue Prescrire. 2012, Vol 32, Num 342, issn 0247-7750, p. 268Article

Nicorandil-induced oral ulceration: report of 3 cases and review of the Japanese literatureYAMAMOTO, Kazuhiko; MATSUSUE, Yumiko; HORITA, Satoshi et al.Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2011, Vol 112, Num 6, pp 754-759, issn 1079-2104, 6 p.Article

KATP channel openers of the benzopyran type reach their binding site via the cytosolSTEPHAN, D; SALAMON, E; WEBER, H et al.British journal of pharmacology. 2006, Vol 149, Num 2, pp 199-205, issn 0007-1188, 7 p.Article

The effect of a nicorandil congener on isolated human myometriumPARIMALA, K; PEEDICAYIL, Jacob; PEEDICAYIL, Abraham et al.European journal of obstetrics, gynecology, and reproductive biology. 2006, Vol 126, Num 2, pp 176-179, issn 0301-2115, 4 p.Article

Effect of the ATP-sensitive potassium channel opener ZM226600 on cystometric parameters in rats with ligature-intact, partial urethral obstructionPINNA, Christian; SANVITO, Paola; BOLEGO, Chiara et al.European journal of pharmacology. 2005, Vol 516, Num 1, pp 71-77, issn 0014-2999, 7 p.Article

Tetramethylpyrazine as potassium channel opener to lower calcium influx into cultured aortic smooth muscle cellsTSAI, Chin-Chuan; LAI, Tung-Yuan; HUANG, Wei-Chan et al.Planta medica. 2003, Vol 69, Num 6, pp 557-558, issn 0032-0943, 2 p.Article

Multiple-dose, linear, dose-proportional pharmacokinetics of retigabine in healthy volunteersFERRON, Geraldine M; PAUL, Jeffrey; FRUNCILLO, Richard et al.Journal of clinical pharmacology. 2002, Vol 42, Num 2, pp 175-182, issn 0091-2700Article

Structural basis for the interference between nicorandil and sulfonylurea actionREIMANN, Frank; ASHCROFT, Frances M; GRIBBLE, Fiona M et al.Diabetes (New York, NY). 2001, Vol 50, Num 10, pp 2253-2259, issn 0012-1797Article

Pharmacokinetic/pharmacodynamic evaluation of a novel potassium channel opener, SKP-450, in healthy volunteersJANG, I.-J; YU, K.-S; YOO, S. E et al.Journal of clinical pharmacology. 2000, Vol 40, Num 7, pp 752-761, issn 0091-2700Article

Clinical pharmacokinetics of vasodilators : Part IKIRSTEN, R; NELSON, K; KIRSTEN, D et al.Clinical pharmacokinetics. 1998, Vol 34, Num 6, pp 457-482, issn 0312-5963Article

Studies of the KATP channel opening activity of the new dihydropyridine compound 9-(3-cyanophenyl)-3,4,6,7,9,10-hexahydro-1,8-(2H,5H)-acridinedione in bladder detrusor in vitroLI, J. H; YASAY, G. D; KAU, S. T et al.Arzneimittel-Forschung. 1996, Vol 46, Num 5, pp 525-530, issn 0004-4172Article

Nicorandil Associated Colonic Ulceration: Case Series of an Increasingly Recognized ComplicationLEE, Bee C; ALLEN, Patrick B; CADDY, Grant R et al.Digestive diseases and sciences. 2011, Vol 56, Num 8, pp 2404-2408, issn 0163-2116, 5 p.Article

Nicorandil: A curable cause of anal ulceration to be known..FOURTI, M. A; DE PARADES, V; ATIENZA, P et al.Gastroentérologie clinique et biologique. 2010, Vol 34, Num 11, pp 639-640, issn 0399-8320, 2 p.Article

Application of genetic algorithm-support vector machine (GA-SVM) for prediction of BK-channels activityPOURBASHEER, Eslam; RIAHI, Siavash; MOHAMMAD REZA GANJALI et al.European journal of medicinal chemistry. 2009, Vol 44, Num 12, pp 5023-5028, issn 0223-5234, 6 p.Article

Separation of maxi-K channel opening 3-substitued-4-arylquinolinone atropisomers by enantioselective supercritical fluid chromatographyQIAN-CUTRONE, Jingfang; DASGUPTA, Bireshwar; KOZLOWSKI, Edward S et al.Journal of pharmaceutical and biomedical analysis. 2008, Vol 48, Num 4, pp 1120-1126, issn 0731-7085, 7 p.Article

A new ATP-sensitive potassium channel opener protects endothelial function in cultured aortic endothelial cellsHAI WANG; CHAOLIANG LONG; ZHIBIAN DUAN et al.Cardiovascular research. 2007, Vol 73, Num 3, pp 497-503, issn 0008-6363, 7 p.Article

Disposition and metabolism of 2-2(1, 3-dioxolan-2-yl)-2-methyl-4-(2'-oxopyrrolidin-1 -yl)-6-nitro-2H-1-benzopyran (SKP-450) in ratsMINSUN BAEK; HAK SOON CHUNG; YUNJE KIM et al.Drug metabolism and disposition. 1999, Vol 27, Num 4, pp 510-516, issn 0090-9556Article

Levosimendan enhances cardiac performance after cardiopulmonary bypass : A prospective, randomized placebo-controlled trialNIJHAWAN, N; NICOLOSI, A. C; MONTGOMERY, M. W et al.Journal of cardiovascular pharmacology. 1999, Vol 34, Num 2, pp 219-228, issn 0160-2446Article

  • Page / 18